BIORBYT LTD. Non-Antibody Products — page 7 of 8
Non-Antibody Products
Page 7,959 of 8,115
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| VSTM2L siRNA (Human) | siRNA to inhibit VSTM2L expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1853295 | More Info |
| VSTM2L siRNA (Mouse) | siRNA to inhibit VSTM2L expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1835086 | More Info |
| VSTM1 Protein, Human, Recombinant (hFc) | Purity 98.00%. MW: approxiamtely 40.6 kDa | 50 ug | orb1957123 | More Info |
| VSTM5 Protein, Human, Recombinant (hFc) | Purity 98.00%. The protein has a predicted MW of 40 kDa. Due to glycosylat… | 100 ug | orb1960313 | More Info |
| VSTM1 Protein, Human, Recombinant (His) | Purity 98.00%. MW: approxiamtely 15 kDa | 50 ug | orb1957131 | More Info |
| VSTM5 Protein, Mouse, Recombinant (hFc) | Purity 98.00%. The protein has a predicted MW of 40.1 kDa. Due to glycosyl… | 100 ug | orb1959768 | More Info |
| VSTM1 Recombinant Protein | VSTM1 Recombinant Protein. Purity >95% as determined by reducing SDS-PAGE.… | 0.05 mg | orb1228492 | More Info |
| VSTM3 Recombinant Protein | VSTM3 Recombinant Protein. Purity > 92% as determined by SDS-PAGE. MW: 39.… | 0.1 mg | orb1227861 | More Info |
| VSTM1 siRNA (Human) | siRNA to inhibit VSTM1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1851239 | More Info |
| VSTM4 siRNA (Human) | siRNA to inhibit VSTM4 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1852074 | More Info |
| VSTM5 siRNA (Human) | siRNA to inhibit VSTM5 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1850500 | More Info |
| VSTM5 siRNA (Mouse) | siRNA to inhibit VSTM5 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1841398 | More Info |
| VSTM5 siRNA (Rat) | siRNA to inhibit VSTM5 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1827247 | More Info |
| VSV-G Peptide | Purity > 95%. MW: 1339.5 | 10 mg, 1 mg, 5 mg | orb372921 | More Info |
| VSV-G peptide | VSV-G peptide. Purity > 95%. | 5 mg, 1 mg | orb71106 | More Info |
| VSV-G Peptide acetate(103425-05-4 free base) | VSV-G Peptide acetate(103425-05-4 free base). Purity 99.79%. MW: 1399.58 | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg | orb1296616 | More Info |
| VSX1 | n/a | 10 ug | orb529864 | More Info |
| VSX2 | n/a | 10 ug | orb529851 | More Info |
| VSX1 Human Over-expression Lysate | Transient overexpression lysate of visual system homeobox 1 (VSX1), transc… | 100 ug | orb1348070 | More Info |
| VSX1 Human Over-expression Lysate | Transient overexpression lysate of visual system homeobox 1 (VSX1), transc… | 100 ug | orb1355286 | More Info |
| VSX1 Human Over-expression Lysate | VSX1 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1368410 | More Info |
| VSX1 siRNA (Human) | siRNA to inhibit VSX1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1858918 | More Info |
| VSX2 siRNA (Human) | siRNA to inhibit VSX2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1850996 | More Info |
| VSX1 siRNA (Mouse) | siRNA to inhibit VSX1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1838069 | More Info |
| VSX2 siRNA (Mouse) | siRNA to inhibit VSX2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1848584 | More Info |
| VT103 | Purity 98.00%. MW: 410.41 | 100 mg, 25 mg, 50 mg, 500 mg, 10 mg, 5 mg, 1 mg | orb1687961 | More Info |
| VT104 | Purity 99%. MW: 420.43 | 50 mg, 25 mg, 10 mg, 5 mg, 1 mg, 100 mg | orb1741387 | More Info |
| VT-105 | Purity 98.00%. MW: 421.42 | 5 mg, 50 mg, 100 mg | orb1739842 | More Info |
| VT107 | Purity 98.00%. MW: 435.44 | 100 mg, 50 mg, 5 mg, 500 mg, 25 mg, 10 mg, 1 mg | orb1694524 | More Info |
| VT-1161 | VT-1161 is a potent, highly-selective, and oral fungal CYP51 inhibitor wit… | 1 g, 250 mg, 100 mg | orb1785924 | More Info |
| VT-1598 | Purity 98.00%. MW: 584.535 | 100 mg, 50 mg, 5 mg | orb1685913 | More Info |
| VT-1598 | VT-1598 is a potent, high-affinity, oral inhibitor of fungal sterol 14&alp… | 5 mg | orb1785978 | More Info |
| VTA1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb603050 | More Info |
| VTA1 Human Over-expression Lysate | Transient overexpression lysate of Vps20-associated 1 homolog (S. cerevisi… | 100 ug | orb1348949 | More Info |
| VTA1 Human Over-expression Lysate | VTA1 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1369289 | More Info |
| VTA1 siRNA (Human) | siRNA to inhibit VTA1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1858441 | More Info |
| VTA1 siRNA (Mouse) | siRNA to inhibit VTA1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1842790 | More Info |
| VTCN1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb600359 | More Info |
| VTCN1 Immunizing peptide | n/a | 100 ug | orb16987 | More Info |
| VTCN1 Peptide | n/a | 0.05 mg | orb1232110 | More Info |
| VTCN1 Peptide | n/a | 0.1 mg | orb1233373 | More Info |
| VTCN1 Recombinant Protein | VTCN1 Recombinant Protein. Purity > 90% as determined by SDS-PAGE. MW: 26.… | 0.1 mg | orb1228178 | More Info |
| VTCN1 siRNA (Human) | siRNA to inhibit VTCN1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1855778 | More Info |
| VTCN1 siRNA (Mouse) | siRNA to inhibit VTCN1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1835705 | More Info |
| VTCN1 siRNA (Rat) | siRNA to inhibit VTCN1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1829506 | More Info |
| VT101 free base | Purity 98.00%. MW: 312.384 | 5 mg, 50 mg, 100 mg | orb1740546 | More Info |
| VT-102 free base | Purity 98.00%. MW: 470.389 | 5 mg, 50 mg, 100 mg | orb1738056 | More Info |
| vtg1 Protein | Recombinant Oncorhynchus mykiss Vitellogenin(vtg1),partial. Purity >85% as… | 20 ug, 100 ug, 1 mg | orb1478089 | More Info |
| VTI1A | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb601220 | More Info |
| VTI1A Human Over-expression Lysate | Transient overexpression lysate of vesicle transport through interaction w… | 100 ug | orb1353083 | More Info |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Return to Profile